XML 50 R19.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Measurements
3 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements
FAIR VALUE MEASUREMENTS

Fair value is defined under GAAP as the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. GAAP requires that valuation techniques maximize the use of observable inputs and minimize the use of unobservable inputs. GAAP also establishes a fair value hierarchy which prioritizes the valuation inputs into three broad levels. Based on the underlying inputs, each fair value measurement in its entirety is reported in one of three levels. These levels are:

Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level 2: Significant observable inputs other than quoted prices included within Level 1, such as quoted prices for similar (as opposed to identical) assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs other than quoted prices that are observable or can be corroborated by observable market data.

Level 3: Significant unobservable inputs that reflect a company’s own assumptions about the assumptions market participants would use in pricing an asset or liability based on the best information available in the circumstances.

The Company's assets measured at fair value on a recurring basis consist of investment securities available for sale and investments in equity securities. The estimated fair values of MBS are based upon market prices of similar securities or observable inputs (Level 2). The estimated fair values of mutual funds are based upon quoted market prices (Level 1).

The Company had no liabilities measured at fair value on a recurring basis at December 31, 2019 and September 30, 2019. The Company's assets measured at estimated fair value on a recurring basis at December 31, 2019 and September 30, 2019 were as follows (dollars in thousands):
December 31, 2019
Estimated Fair Value
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Available for sale investment securities
 
 
 
 
 
 
 
   MBS: U.S. government agencies
$

 
$
37,873

 
$

 
$
37,873

Investments in equity securities
 
 
 
 
 
 
 
   Mutual funds
953

 

 

 
953

Total
$
953

 
$
37,873

 
$

 
$
38,826

 
 
 
 
 
 
 
 
September 30, 2019
Estimated Fair Value
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Available for sale investment securities
 
 
 
 
 
 
 
   MBS: U.S. government agencies
$

 
$
22,532

 
$

 
$
22,532

Investments in equity securities
 
 
 
 
 
 
 
   Mutual funds
958

 

 

 
958

Total
$
958

 
$
22,532

 
$

 
$
23,490



There were no transfers among Level 1, Level 2 and Level 3 during the three months ended December 31, 2019 and the year ended September 30, 2019.

The Company may be required, from time to time, to measure certain assets and liabilities at fair value on a non-recurring basis in accordance with GAAP.  These include assets that are measured at the lower of cost or market value that were recognized at fair value below cost at the end of the period.

The Company uses the following methods and significant assumptions to estimate fair value on a non-recurring basis:

Impaired Loans: The estimated fair value of impaired loans is calculated using the collateral value method or on a discounted cash flow basis.  The specific reserve for collateral dependent impaired loans is based on the estimated fair value of the collateral less estimated costs to sell, if applicable.  In some cases, adjustments are made to the appraised values due to various factors including age of the appraisal, age of comparables included in the appraisal and known changes in the market and in the collateral. Such adjustments may be significant and typically result in a Level 3 classification of the inputs for determining fair value. Impaired loans are evaluated on a quarterly basis for additional impairment and adjusted accordingly.

Investment Securities Held to Maturity: The estimated fair value of investment securities held to maturity is based upon the assumptions market participants would use in pricing the investment security.  Such assumptions include quoted market prices (Level 1), market prices of similar securities or observable inputs (Level 2) and unobservable inputs such as dealer quotes, discounted cash flows or similar techniques (Level 3).

OREO and Other Repossessed Assets, net:  OREO and other repossessed assets are recorded at estimated fair value less estimated costs to sell.  Estimated fair value is generally determined by management based on a number of factors, including third-party appraisals of estimated fair value in an orderly sale.  Estimated costs to sell are based on standard market factors.  The valuation of OREO and other repossessed assets is subject to significant external and internal judgment (Level 3).

The following table summarizes the balances of assets measured at estimated fair value on a non-recurring basis at December 31, 2019 (dollars in thousands):
 
Estimated Fair Value
 
Level 1
 
Level 2
 
Level 3
Impaired loans:
 
 
 
 
 
Mortgage loans:
 
 
 
 
 
Land
$

 
$

 
$
111

Consumer loans:
 
 
 
 
 
Other

 

 
6

  Commercial business loans

 

 
347

Total impaired loans

 

 
464

 
 
 
 
 
 
OREO and other repossessed assets

 

 
1,659

Total
$

 
$

 
$
2,123



The following table presents quantitative information about Level 3 fair value measurements for financial instruments measured at fair value on a non-recurring basis as of December 31, 2019 (dollars in thousands):
 
 Estimated
Fair Value
 
 Valuation
Technique(s)
 
 Unobservable Input(s)
 
 Range
Impaired loans
$
464

 
Market approach
 
Appraised value less estimated selling costs
 
NA
 
 
 
 
 
 
 
 
OREO and other repossessed assets
$
1,659

 
Market approach
 
Lower of appraised value or listing price less estimated selling costs
 
NA


The following table summarizes the balances of assets measured at estimated fair value on a non-recurring basis at September 30, 2019 (dollars in thousands):
 
Estimated Fair Value
 
Level 1
 
Level 2
 
Level 3
Impaired loans:
 
 
 
 
 
Mortgage loans:
 
 
 
 
 
Land
$

 
$

 
$
114

Consumer loans:
 

 
 

 
 

Home equity and second mortgage

 

 

Other

 

 
6

  Commercial business loans

 

 
408

Total impaired loans

 

 
528

Investment securities – held to maturity:
 

 
 

 
 

MBS - private label residential

 
2

 

OREO and other repossessed assets

 

 
1,683

Total
$

 
$
2

 
$
2,211



The following table presents quantitative information about Level 3 fair value measurements for financial instruments measured at fair value on a non-recurring basis as of September 30, 2019 (dollars in thousands):
 
 Estimated
Fair Value
 
 Valuation
Technique(s)
 
 Unobservable Input(s)
 
 Range
Impaired loans
$
528

 
Market approach
 
Appraised value less estimated selling costs
 
NA
 
 
 
 
 
 
 
 
OREO and other repossessed assets
$
1,683

 
Market approach
 
Lower of appraised value or listing price less estimated selling costs
 
NA


GAAP requires disclosure of estimated fair values for certain financial instruments. Such estimates are subjective in nature, and significant judgment is required regarding the risk characteristics of various financial instruments at a discrete point in time. Therefore, such estimates could vary significantly if assumptions regarding uncertain factors were to change. In addition, as the Company normally intends to hold the majority of its financial instruments until maturity, it does not expect to realize many of the estimated amounts disclosed. The disclosures also do not include estimated fair value amounts for certain items which are not defined as financial instruments but for which may have significant value. The Company does not believe that it would be practicable to estimate a represented fair value for these types of items as of December 31, 2019 and September 30, 2019. Because GAAP excludes certain items from fair value disclosure requirements, any aggregation of the fair value amounts presented would not represent the underlying value of the Company. Additionally, in accordance with ASU No. 2016-01, which the Company adopted on October 1, 2018 on a prospective basis, the Company uses the exit price notion in calculating the fair values of financial instruments not measured at fair value on a recurring basis.

The recorded amounts and estimated fair values of financial instruments were as follows as of December 31, 2019 and September 30, 2019 (dollars in thousands):
 
December 31, 2019
 
 
 
 
 
Fair Value Measurements Using:
 
Recorded
Amount
 
 Estimated Fair Value
 
 
Level 1
 
 
Level 2
 
 
Level 3
Financial assets
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
118,851

 
$
118,851

 
$
118,851

 
$

 
$

CDs held for investment
76,249

 
76,249

 
76,249

 

 

Investment securities
76,953

 
79,114

 
2,997

 
76,117

 

Investments in equity securities
953

 
953

 
953

 

 

FHLB stock
1,437

 
1,437

 
1,437

 

 

Other investments
3,000

 
3,000

 
3,000

 

 

Loans held for sale
5,420

 
5,501

 
5,501

 

 

Loans receivable, net
913,150

 
917,475

 

 

 
917,475

     Accrued interest receivable
3,665

 
3,665

 
3,665

 

 

 
 
 
 
 
 
 
 
 
 
Financial liabilities
 

 
 

 
 

 
 

 
 

Certificates of deposits
165,408

 
166,432

 

 

 
166,432

Accrued interest payable
351

 
351

 
351

 

 

 
September 30, 2019
 
 
 
 
 
Fair Value Measurements Using:
 
Recorded
Amount
 
 Estimated Fair Value
 
 
Level 1
 
 
Level 2
 
 
Level 3
Financial assets
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
143,015

 
$
143,015

 
$
143,015

 
$

 
$

CDs held for investment
78,346

 
78,346

 
78,346

 

 

Investment securities
53,634

 
55,112

 
3,949

 
51,163

 

Investments in equity securities
958

 
958

 
958

 

 

FHLB stock
1,437

 
1,437

 
1,437

 

 

Other investments
3,000

 
3,000

 
3,000

 

 

Loans held for sale
6,071

 
6,260

 
6,260

 

 

Loans receivable, net
886,662

 
892,495

 

 

 
892,495

     Accrued interest receivable
3,598

 
3,598

 
3,598

 

 

 
 
 
 
 
 
 
 
 
 
Financial liabilities
 

 
 

 
 

 
 

 
 

Certificates of deposits
165,655

 
166,852

 

 

 
166,852

Accrued interest payable
333

 
333

 
333